Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer.

Carlos H Barcenas Juhee Song Rashmi K Murthy Akshara Singareeka Raghavendra Yisheng LiLimin HsuRobert W Carlson Debasish Tripathy Gabriel N Hortobagyi

Published in: JCO clinical cancer informatics (2021)

We have generated and validated a robust prognostic OS model for MBC. This model can be used in clinical decision making and stratification in clinical trials.

Keyphrases

clinical trial
metastatic breast cancer
decision making
randomized controlled trial
study protocol
double blind